Literature DB >> 6261010

Efficiency of processing of viral RNA during the early and late phases of productive infection by polyoma virus.

N H Acheson.   

Abstract

The efficiency of processing of polyoma viral RNA and of its export from nucleus to cytoplasm was measured in primary mouse kidney cells by comparing the initial rates of incorporation of [3H]uridine into cytoplasmic and nuclear viral RNA. Appropriate methods of cell fractionation were chosen to maximize yields of cytoplasmic RNA and to minimize leakage of nuclear RNA. Incorporation of [3H]uridine into cellular 4S RNA in the cytoplasm was followed to monitor pool equilibration and maintenance of an excess of radioactive precursor throughout the experimental period. During the early phase of infection (9 to 11 h, in the presence of 5-fluorodeoxyuridine), viral RNA was rapidly and efficiently exported from nucleus to cytoplasm. Viral RNA appeared in the cytoplasm within 6 min of its synthesis, greater than half of the viral RNA synthesized in the nucleus was exported to the cytoplasm. In contrast, during the late phase of infection (28 to 30 h), viral RNA was exported more slowly, appearing in the cytoplasm 12 to 20 min after its synthesis, and much less efficiently-only 5% of late nuclear transcripts was exported. The poor efficiency of processing of late viral RNA may be, in part, a result of (i) the presence in nuclear transcripts of non-mRNA sequences which are removed during processing; (ii) the presence in nuclear transcripts of multiple copies of mRNA sequences, only one of which is incorporated into mature mRNA; and (iii) inefficient polyadenylation of viral nuclear RNA.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6261010      PMCID: PMC171050     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  26 in total

1.  High stability of messenger RNA in growing cultured cells.

Authors:  J R Greenberg
Journal:  Nature       Date:  1972-11-10       Impact factor: 49.962

2.  Symmetrical in vivo transcription of polyoma DNA and the separation of self-complementary viral and cell RNA.

Authors:  Y Aloni; H Locker
Journal:  Virology       Date:  1973-08       Impact factor: 3.616

3.  Localization and kinetics of formation of nuclear heterodisperse RNA, cytoplasmic heterodisperse RNA and polyribosome-associated messenger RNA in HeLa cells.

Authors:  S Penman; C Vesco; M Penman
Journal:  J Mol Biol       Date:  1968-05-28       Impact factor: 5.469

4.  On the lability of poly(A) sequences during extraction of messenger RNA from polyribosomes.

Authors:  R P Perry; J La Torre; D E Kelley; J R Greenberg
Journal:  Biochim Biophys Acta       Date:  1972-03-14

5.  Reagents which reduce interactions between ribosomal RNA and rapidly labelled RNA from rat liver.

Authors:  J H Parish; K S Kirby
Journal:  Biochim Biophys Acta       Date:  1966-12-21

6.  Characterization of the messenger RNA released from L cell polyribosomes as a result of temperature shock.

Authors:  G Schochetman; R P Perry
Journal:  J Mol Biol       Date:  1972-02-14       Impact factor: 5.469

7.  RNA metabolism in the HeLa cell nucleus.

Authors:  S Penman
Journal:  J Mol Biol       Date:  1966-05       Impact factor: 5.469

8.  hnRNA size and processing as related to different DNA content in two dipterans: Drosophila and Aedes.

Authors:  J Lengyel; S Penman
Journal:  Cell       Date:  1975-07       Impact factor: 41.582

9.  Characterization of late polyoma mRNA.

Authors:  E Buetti
Journal:  J Virol       Date:  1974-08       Impact factor: 5.103

10.  Transcription of the polyoma virus genome: synthesis and cleavage of giant late polyoma-specific RNA.

Authors:  N H Acheson; E Buetti; K Scherrer; R Weil
Journal:  Proc Natl Acad Sci U S A       Date:  1971-09       Impact factor: 11.205

View more
  13 in total

1.  Use of a novel S1 nuclease RNA-mapping technique to measure efficiency of transcription termination on polyomavirus DNA.

Authors:  R W Tseng; N H Acheson
Journal:  Mol Cell Biol       Date:  1986-05       Impact factor: 4.272

2.  Nuclear antisense RNA induces extensive adenosine modifications and nuclear retention of target transcripts.

Authors:  M Kumar; G G Carmichael
Journal:  Proc Natl Acad Sci U S A       Date:  1997-04-15       Impact factor: 11.205

3.  Duplication of functional polyadenylation signals in polyomavirus DNA does not alter efficiency of polyadenylation or transcription termination.

Authors:  J Lanoix; R W Tseng; N H Acheson
Journal:  J Virol       Date:  1986-06       Impact factor: 5.103

4.  Targeted nuclear antisense RNA mimics natural antisense-induced degradation of polyoma virus early RNA.

Authors:  Z Liu; D B Batt; G G Carmichael
Journal:  Proc Natl Acad Sci U S A       Date:  1994-05-10       Impact factor: 11.205

5.  The sequence and context of the 5' splice site govern the nuclear stability of polyoma virus late RNAs.

Authors:  N L Barrett; X Li; G G Carmichael
Journal:  Nucleic Acids Res       Date:  1995-12-11       Impact factor: 16.971

6.  Characterization of the polyomavirus late polyadenylation signal.

Authors:  D B Batt; G G Carmichael
Journal:  Mol Cell Biol       Date:  1995-09       Impact factor: 4.272

7.  Kinetics and efficiency of polyadenylation of late polyomavirus nuclear RNA: generation of oligomeric polyadenylated RNAs and their processing into mRNA.

Authors:  N H Acheson
Journal:  Mol Cell Biol       Date:  1984-04       Impact factor: 4.272

Review 8.  Antisense RNA: function and fate of duplex RNA in cells of higher eukaryotes.

Authors:  M Kumar; G G Carmichael
Journal:  Microbiol Mol Biol Rev       Date:  1998-12       Impact factor: 11.056

9.  Nuclear antisense RNA. An efficient new method to inhibit gene expression.

Authors:  Z Liu; G G Carmichael
Journal:  Mol Biotechnol       Date:  1994-10       Impact factor: 2.695

10.  Kinetics of accumulation and processing of simian virus 40 RNA in Xenopus laevis oocytes injected with simian virus 40 DNA.

Authors:  T J Miller; D L Stephens; J E Mertz
Journal:  Mol Cell Biol       Date:  1982-12       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.